← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 30, 2002Last known activity
Mar 1, 2024
Timeline
1940s
- Jan 1, 1946
National Multiple Sclerosis Society— Founded
Drugs by trial phase (27 distinct, 23 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT06170970CollaboratorPhase 2Mar 1, 2024
- NCT03853746CollaboratorPhase 4Apr 1, 2019
- NCT03621761CollaboratorPhase 4Oct 31, 2018
- NCT03500289CollaboratorPhase 1/Phase 2Aug 10, 2018
- NCT03051646CollaboratorEarly Phase 1Jan 13, 2017
- NCT02011451CollaboratorPhase 2Dec 1, 2015
- NCT02104661CollaboratorPhase 2Oct 1, 2014
- NCT02133664CollaboratorPhase 1/Phase 2Jun 1, 2014
- NCT01982942CollaboratorPhase 2Nov 1, 2013
- NCT01848327CollaboratorN/AFeb 1, 2013
- NCT01470521CollaboratorPhase 2Dec 1, 2011
- NCT01451593CollaboratorPhase 2Nov 1, 2011
- NCT01191996CollaboratorPhase 1/Phase 2Aug 1, 2010
- NCT00645749CollaboratorPhase 1Jul 1, 2008
- NCT00467584CollaboratorPhase 3Jul 1, 2007
Details
- Founded
- New York, NY, US Jan 1, 1946
- Last known activity
- Mar 1, 2024